The head and neck cancer team leads in the diagnosis, treatment, and rehabilitation of both benign and malignant diseases of the head and neck region. Our team employs a multidisciplinary approach to diagnose and treat all types and stages of cancers that occur in the head and neck region, including:
- Oral cancer (lip, mouth, tongue, palate)
- Oropharyngeal cancer (tonsil, tongue base, soft palate) - including da Vinci® Robotic Surgery (TORS)
- Laryngeal cancer (voice box)
- Hypopharyngeal cancer (throat and swallowing passage cancer)
- Benign and malignant thyroid disease
- Parathyroid disease (Hyperparathyroidism) - including Minimally Invasive Radioguided Parathyroidectomy
- Salivary gland tumors
- Cutaneous malignancies of the head and neck
Advanced Diagnosis and Treatment for Improved Care
Patients are thoroughly evaluated by our team of physicians and caregivers in order to make the most accurate diagnosis and treatment plan. We provide patients with the information needed to understand their disease and decide on the best treatment plan for them. Treatments may include surgery, radiation, and/or chemotherapy as well as medical therapy. Throughout treatment, we emphasize ongoing communication with patients, families, and referring physicians.
Advanced Cancer Care by Multidisciplinary Team
As an academic medical center, patients with head and neck cancer benefit from innovations in cancer care through research at Penn State Health Milton S. Hershey Medical Center. All cancer care decisions are reviewed by a multidisciplinary team including surgeons, radiation and medical oncologists, pathologists, and radiologists so patients have the knowledge and expertise from a team of nationally recognized surgical specialists for every step of their individualized care.
For questions or further information, email the Nurse Facilitator Patrice Saurman, RN, BSN, at firstname.lastname@example.org.
A safer and less invasive approach to surgically treat hyperparathyroidism
A less invasive treatment option
- The Medical Minute: Clearing up common myths about psoriasis Psoriasis is a misunderstood disease, often kept under wraps by sufferers who want to hide their skin lesions. This week, Dr. Sara Ferguson, a dermatologist at Penn State Medical Group in State College, separates fact from myth about psoriasis and the various treatment options.More...
- How parents cope with stress of the NICU affects family dynamics Understanding how parents cope while their child is in the neonatal intensive care unit (NICU) could lead to better support for the family and a more successful transition to home when the baby is healthy, according to Penn State College of Medicine and Penn State Harrisburg researchers. Parental use of religious and secular coping strategies while their prematurely born baby receives intensive medical care may affect the family's interactions.More...
- Penn State Cancer Institute recognized by Becker’s Hospital Review Penn State Cancer Institute has been named among the “100 Hospitals and Health Systems With Great Oncology Programs” by Becker’s Hospital Review, a leading source of business and legal information for healthcare industry leaders.More...
- New care plan improves outcomes for Crohn's disease complication The first published combined medical and surgical care plan for managing septic perianal Crohn's disease, a serious complication that occurs in around 40 percent of Crohn's disease patients, has been developed by researchers at Penn State College of Medicine. The plan and its results took more than a decade to develop and are based on patient outcomes.More...